Zoom Logo

RADx Webinar Series - Shared screen with speaker view
Jeff Zephirin
38:08
Hello, everyone!
Michele Liston
59:19
703 projects were evaluated by the viability panel, and 148 went through the "shark tank"/Deep Dive process
Leslie Marshall - NIH OAR (She/Her)
01:00:35
I need to leave for a conflicting meeting. Will the recording be made available later?
Tracy McMahon
01:01:34
Yes, a recording will be available on poctrn.org!
Penny Carleton
01:01:37
Yes, recording and PDF of slides will be available within approximately 1 week on POCTRN website www.poctrn.org
Jerry Hu
01:01:51
Do the CMs listed also produce biologics; what do they do if their device needs reagents (e.g., antibodies)?
Leslie Marshall - NIH OAR (She/Her)
01:01:57
Thank you!
David Gottfried
01:11:35
Given the time that has past since the start of RADx, have some of the small OEMs acquired the capacity for in-house manufacturing now?
Andrew Potter
01:15:17
Two examples receiving DOD funding for increased capacity are Ellume and Orasure
Bob Storey
01:16:15
Considering the likely over capacity that is related to case load reduction - is it likely that a number of the newly minted manufacturing sites will revert to broader CM work? Are we seeing signals of that?
Klaus Schäfer
01:18:52
How is the Government supporting smaller Companies to maintain scale (through policies and long term funding), when it is economically unsustainable over time. , because the Government has a history of not being a reliable Partner in maintaining infrastructure?
Jerry Hu
01:21:13
Biomanufacturing is plagued with time (e.g., for incubation) and scale-up issues, but reagent are oftentimes essential components of diagnostics; what are your general thoughts on the state of CMs for biomanufacturing (e.g., cells, antibodies)? Thank you.
David Gottfried
01:21:40
Regarding point #1 on your Lessons Learned, was the RADx funnel too open? Should it have been more selective at the first stage?
Jerry Hu
01:28:04
Thank you!
Marina Sala de Medeiros
01:28:59
Thank you!
Jeff Zephirin
01:29:01
Thank you!
Janice Layugan
01:29:06
Thanks so much.